Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,399 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Recruiting

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Universitaetsklinikum St. Poelten /ID# 221152 Sankt Pölten, Lower Austria, Austria
  • Medizinische Universitaet Graz /ID# 221155 Graz, Styria, Austria
  • Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 Salzburg, Austria
  • Hanusch Krankenhaus /ID# 221151 Vienna, Austria
View all 72 locations
View Trial Details
Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

NCT04269902

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 632 locations
View Trial Details
Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

NCT05947851

Conditions
CLL, Chronic Disease, Disease Attributes, +18 more
Locations
  • Highlands Oncology Group ( Site 5405) Springdale, Arkansas, United States
  • MemorialCare Health System - Long Beach Medical Center ( Site 5421) Long Beach, California, United States
  • Memorial Hospital West ( Site 5410) Pembroke Pines, Florida, United States
  • Oregon Health and Science University ( Site 5425) Portland, Oregon, United States
View all 79 locations
View Trial Details
Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

NCT06136559

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • USA Mitchell Cancer Institute ( Site 0014) Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center ( Site 0059) Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051) Phoenix, Arizona, United States
  • Arizona Oncology Associates - NAHOA ( Site 8007) Prescott, Arizona, United States
View all 203 locations
View Trial Details
Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07218341

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
  • Cancer Specialists, LLC Jacksonville, Florida, United States
  • Minnesota Oncology Hematology, P.A. Coon Rapids, Minnesota, United States
View all 50 locations
View Trial Details

Related conditions